Literature DB >> 9385928

Giant cell arteritis in association with cerebral amyloid angiopathy: immunohistochemical and molecular studies.

K H Anders1, Z Z Wang, M Kornfeld, F Gray, V Soontornniyomkij, L A Reed, M N Hart, M Menchine, D L Secor, H V Vinters.   

Abstract

Giant cell arteritis (GCA) usually manifests as a transmural vascular infiltrate of mononuclear and multinucleated giant cells (MNGC). We describe six patients with GCA associated with severe cerebral amyloid angiopathy (CAA), all with cerebral hemorrhage or varying degrees of cerebral infarct, and histological evidence of Alzheimer's disease (cortical CAA often predominating over senile plaques and neurofibrillary tangles). One case showed mostly cortical involvement (with old microhemorrhages), and the others were primarily leptomeningeal (with involvement of the underlying cortex and extensive encephalomalacia of adjacent brain). Many vessels with CAA exhibited a pronounced adventitial and perivascular infiltrate of lymphocytes, histiocytes, and MNGC. Immunohistochemical staining showed deposition of beta/A4 peptide primarily in the thickened media of CAA vessels, and within the cytoplasm of MNGC--suggesting phagocytosis of insoluble peptide. Cystatin C antibody stained vascular amyloid and diffusely highlighted astrocytic and MNGC cytoplasm. HAM56-positive macrophages were frequently seen around amyloid-laden vessels. Anti-smooth muscle actin immunohistochemistry suggests the occurrence of medial destruction by amyloid, with relative preservation of intimal cells. Ultrastructural studies performed in one case confirmed the presence of intracytoplasmic amyloid in MNGC. The GCA seen in these cases of CAA most likely represents a foreign body response to amyloid proteins, causing secondary destruction of the vessel wall. DNA from brain tissues of five affected patients was examined to assess whether mutations were present in exon 17 of the APP gene or exon 2 of the cystatin C gene, a finding that might explain the foreign body giant cell response to amyloid proteins in these cases. However, restriction fragment mapping of amplified gene segments showed that previously described mutations were not present in these cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9385928     DOI: 10.1016/s0046-8177(97)90196-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  11 in total

Review 1.  T-cells in Alzheimer's disease.

Authors:  Terrence Town; Jun Tan; Richard A Flavell; Mike Mullan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  Inflammation complicates an 'age-related' cerebral microangiopathy.

Authors:  Harry V Vinters
Journal:  Can J Neurol Sci       Date:  2011-07       Impact factor: 2.104

3.  Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta.

Authors:  Margaret M Racke; Laura I Boone; Deena L Hepburn; Maia Parsadainian; Matthew T Bryan; Daniel K Ness; Kathy S Piroozi; William H Jordan; Donna D Brown; Wherly P Hoffman; David M Holtzman; Kelly R Bales; Bruce D Gitter; Patrick C May; Steven M Paul; Ronald B DeMattos
Journal:  J Neurosci       Date:  2005-01-19       Impact factor: 6.167

4.  Biopsy-Proven Amyloid-Beta Related Angiitis with Unusual Presentation and Long-Term Follow-Up.

Authors:  Navnika Gupta; Krishna Galla; Michael R Pichler; Rodney D McComb; Jason T Helvey; Pierre Fayad
Journal:  Neurohospitalist       Date:  2022-06-21

5.  Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.

Authors:  Matthew Schrag; Grant McAuley; Justine Pomakian; Arshad Jiffry; Spencer Tung; Claudius Mueller; Harry V Vinters; E Mark Haacke; Barbara Holshouser; Daniel Kido; Wolff M Kirsch
Journal:  Acta Neuropathol       Date:  2010-03       Impact factor: 17.088

Review 6.  Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies.

Authors:  Tamas Revesz; Janice L Holton; Tammaryn Lashley; Gordon Plant; Blas Frangione; Agueda Rostagno; Jorge Ghiso
Journal:  Acta Neuropathol       Date:  2009-02-19       Impact factor: 17.088

7.  Cerebral amyloid angiopathy-related inflammation presenting with steroid-responsive higher brain dysfunction: case report and review of the literature.

Authors:  Hideya Sakaguchi; Akihiko Ueda; Takayuki Kosaka; Satoshi Yamashita; En Kimura; Taro Yamashita; Yasushi Maeda; Teruyuki Hirano; Makoto Uchino
Journal:  J Neuroinflammation       Date:  2011-09-14       Impact factor: 8.322

8.  Brain biopsy in neurologic decline of unknown etiology.

Authors:  Shino Magaki; Tracie Gardner; Negar Khanlou; William H Yong; Noriko Salamon; Harry V Vinters
Journal:  Hum Pathol       Date:  2014-12-31       Impact factor: 3.466

Review 9.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

Review 10.  Innate Immune and Fungal Model of Alzheimer's Disease.

Authors:  Bodo Parady
Journal:  J Alzheimers Dis Rep       Date:  2018-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.